Double-blind controlled trial of γ-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal

Alcohol and Alcoholism

Volumn 37, Issue 1, 2002, Pages 67-73

  Nimmerrichter, Amanda A ^a   Walter, Henriette ^b   Gutierrez Lobos, Karin E ^b   Lesch, Otto M ^b  

^a Anton Proksch Institute   (Austria)

^b University Children's   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; ALCOHOL; CLOMETHIAZOLE; PLACEBO;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NAUSEA; PHYSICAL TOLERANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SEIZURE; SYMPTOMATOLOGY; VERTIGO;

ADULT; ALCOHOLISM; ANXIETY; CHLORMETHIAZOLE; DOUBLE-BLIND METHOD; ETHANOL; FEMALE; HUMANS; MALE; PATIENT DROPOUTS; SODIUM OXYBATE; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; TREMOR;

EID: 0036181841     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects
2. Gamma-hydroxybutyric acid in the treatment of alcohol dependence: Possible craving development for the drug
3. Maintaining abstinence from alcohol with gamma-hydroxybutyric acid
4. γ-Hydroxybutyric acid reducing effect on ethanol intake: Evidence in favour of a substitution mechanism
5. Pharmacological profiles of generalized absence seizures in lethargic, stargazer and gamma-hydroxybutyrate-treated model mice
6. Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate
7. Clonidine in alcohol withdrawal
8. Gamma-hydroxybutyrate: An overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent
9. High sensitivity to gamma-hydroxybutyric acid in ethanol-preferring sP rats
10. Gamma-hydroxybutyric acid induced suppression and prevention of alcohol withdrawal syndrome and relief of craving in alcohol dependent patients
11. Diagnosis of alcoholism - The Munich Alcoholism Test (MALT)
12. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome
13. Gammahydroxybutyric acid in the treatment of alcohol dependence: A double blind study
14. Gamma-hydroxybutyrate: An emerging drug of abuse that causes physical dependence
15. Evaluation of chlormethiazole in treatment for alcohol withdrawal syndrome. Results of a controlled trial
16. The alcohol withdrawal syndrome
17. Controlled trial comparing amobarbital and chlormethiazole in alcohol withdrawal symptoms
18. Delirium tremens: A double-blind comparison of diazepam and barbital treatment
19. Comparison of chlormethiazole (Heminevrin) and chlordiazepoxide (Librium) in the treatment of acute alcohol withdrawal
20. Towards a standardisation for the methodology in treatment research of alcohol abuse and alcoholism
21. Pharmakotherapie des chronischen Alkoholismus
22. Neue Ansätze in der Therapie Alkoholabhängiger
23. Chronic alcoholism: Subtypes useful for therapy and research
24. Alcohol abuse and alcohol dependence
25. The gamma-hydroxybutyrate signalling system in brain: Organization and functional implications
26. The GHB in the treatment of alcoholism: From astinence to craving
27. Pharmacological Management of Alcohol Withdrawal Pharmacological management of alcohol withdrawal: A meta-analysis and evidence-based practice guideline
28. An improved evaluation instrument for substance abuse patients: The addiction severity index
29. Tiapride and chlormethiazole in alcohol withdrawal: A double-blind trial
30. Double blind controlled trial of GHB in two dosages and chlormethiazole in the treatment of alcohol withdrawal syndrome
31. Guidelines on evaluation of treatment of alcohol dependence
32. Integration of pharmacotherapies in the existing programs for the treatment of alcoholics: An international perspective
33. The role of gamma-hydroxybutyric acid in the treatment of alcoholism: From animal to clinical studies
34. 1,4 Butanediol, gamma-hydroxybutyric acid, and ethanol: Relationships and interactions
35. A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome
36. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial
37. Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal
38. Comparative clinical evaluation of chlordiazepoxide and promazine in treatment of alcohol withdrawal syndrome
39. Assessment of the alcohol withdrawal syndrome-validity and reliability of the translated and modified Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-A)
40. Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)
41. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men
42. 'Craving' bei Alkoholabhängigen (Lübecker Craving-Risiko-Rückfall-Fragebogen)
43. Chlordiazepoxide (Librium) compared with meprobamate and promazine (Prozine) for the withdrawal symptoms of acute alcoholism
44. The drug treatment of alcohol withdrawal symptoms: A systematical review
45. Alcohol withdrawal syndrome